-Feng Bai Researcher Activity Profile

Research Author Detailed Information 

Feng Bai Publication Rate By Year

Feng Bai has published 3 paper(s) in 2005, 2 paper(s) in 2006, 6 paper(s) in 2007, 1 paper(s) in 2008, for a total of 12 research publications in total.

Feng F Bai Author Information

LAST NAME: bai

FIRST NAME: feng

INITIALS: F

AFFILIATION:

Papers

Feng Bai's Publication Record

1. p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Year Published: 2007
Lineberger Comprehensive Cancer Center, Department of Biochemistry and Biophysics, Program in Molecular Biology and Biotechnology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
2. [The luminescence characteristic of a new novel coprecipitate rare earths complexes] Year Published: 2005
Institute of Optoelectronics Technology, Laboratory of Materials for Information Storage and Display, Ministry of Railway Key Laboratory, Beijing Jiaotong University, Beijing 100044, China.
3. [Luminescence properties of rare earth complexes Tb(BSA)4] Year Published: 2005
Institute of Optoelectronic Technology, Laboratory of Materials for Information Storage and Display, Beijing Jiaotong University, Beijing 100044, China.
4. [Electroluminescent device based on rare earth terbium complex] Year Published: 2005
Institute of Optoelectronics, Key Laboratory of Information Storage and Display, Beijing Jiaotong University, Beijing 100044, China.
5. [Analysis of the quality of papers dealing with clinical trails in "Chinese Journal of Burns" during 2000-2004 by the standard of evidence-based medicine] Year Published: 2006
Burn Institute, First Affiliated Hospital to PLA General Hospital (Formerly 304 Hospital), Beijing 100037, PR China. cyjburns@yahoo.com.cn
6. [Analysis and evaluation of the articles concerning animal experiments published in Chinese Journal of Burns during 2000 to 2004] Year Published: 2006
Burn Institute, the First Affiliated Hospital to General Hospital of PLA, Beijing, PR China. cyfburns@yahoo.com.cn
7. p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Year Published: 2007
Lineberger Comprehensive Cancer Center, Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA.
8. Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420. Year Published: 2007
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. alberto.broniscer@stjude.org
9. Determination of Cloretazine (VNP40101M) and its active metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS). Year Published: 2007
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, and The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA.
10. White matter integrity of the whole brain is disrupted in first-episode remitted geriatric depression. Year Published: 2007
School of Clinical Medicine, Southeast University, Nanjing, PR China.
11. White matter integrity of the whole brain is disrupted in first-episode remitted geriatric depression. Year Published: 2007
School of Clinical Medicine, Southeast University, Nanjing, PR China.
12. Modified classic risk factors for coronary artery disease in Chinese Han population. Year Published: 2008
Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an Jiaotong University, Xi'an. hanbincui@hotmail.com